Language
English
Publication Date
9-1-2024
Journal
American Journal of Preventive Cardiology
DOI
10.1016/j.ajpc.2024.100715
PMID
39224771
PMCID
PMC11367048
PubMedCentral® Posted Date
8-6-2024
PubMedCentral® Full Text Version
Post-print
Abstract
•Bempedoic acid has been shown to reduce major adverse cardiovascular outcomes in patients unable to take statins due to statin-associated side effects.•Analysis of CLEAR Outcomes trial data reveals possible differences in baseline characteristics between the primary and secondary prevention subgroups.•Further research is needed to optimize use of bempedoic acid and clarify its impact on cardiovascular outcomes in diverse patient populations.
Published Open-Access
yes
Recommended Citation
Mousavi, Idine; Nambi, Vijay; Abushamat, Layla A; et al., "Bempedoic Acid in Secondary Prevention" (2024). Faculty and Staff Publications. 4166.
https://digitalcommons.library.tmc.edu/baylor_docs/4166
Graphical Abstract